Hyun Shim, DPM
Foot & Ankle Surgery · Philadelphia, PANPI 1760919062
Payments from drug & device makers
Across 49 payments — averaging $83.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Liberty Surgical Inc.$1K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Stryker$386
- Treace Medical Concepts, Inc.$301
- Smith+Nephew$240
- Paratek Pharmaceuticals, Inc.$134
- plus $613 from 13 others
What the payments were for
- Food & beverage$1,67341%
- Education$2,40059%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Liberty Surgical Inc. | 1 | $1,200 |
| Gotham Surgical Solutions & Devices, Inc. | 1 | $1,200 |
| Stryker | 5 | $386 |
| Treace Medical Concepts, Inc. | 8 | $301 |
| Smith+Nephew | 6 | $240 |
| Paratek Pharmaceuticals, Inc. | 6 | $134 |
| Nevro Corp. | 5 | $102 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $80 |
| Sanara Medtech Inc. | 1 | $64 |
| Axogen | 1 | $51 |
| Organogenesis Inc. | 1 | $48 |
| Sebela Pharmaceuticals Inc. | 3 | $46 |
| Bonalive Inc | 1 | $44 |
| KCI USA, Inc. | 1 | $40 |
| Novus Surgical Consultants | 1 | $35 |
| Johnson & Johnson | 1 | $28 |
| Orthofix Medical, Inc. | 1 | $27 |
| ERMI LLC | 1 | $24 |
| GRT US Holding, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LAPIPLASTY SYSTEM 1$135
- GRAFIX PL$134
- STRAVIX PL$134
- OASIS MICRO$134
- AUGMENT INJECTABLE$131
- VARIAX$115
How this compares
$4,073 in reported general payments places this provider in the 60th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 33 | $844 |
| Ammonium Lactate | 17 | $418 |
| Cephalexin | 87 | $319 |
| Doxycycline Hyclate | 21 | $168 |
| Methylprednisolone | 19 | $94 |
| Hydrocortisone | 17 | $84 |
| Gabapentin | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Philadelphia
- William BrownellPhiladelphia$43K
- Michael TroianoPhiladelphia$38K
- Jenna BrkichPhiladelphia$25K
- Jennifer vanPhiladelphia$17K
- Roshmi BhattacharyaPhiladelphia$17K
- Ali AnaimPhiladelphia$17K
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.7M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.